Extended Data Fig. 7: Cancer risk in relation to p53 IHC per sample.
From: Genomic copy number predicts esophageal cancer years before transformation
a, Bars show the proportion of aberrant p53 IHC stained samples separated by pathology in samples from progressive patients. The purple bars indicate the percentage of aberrant samples for each pathology. b, The CN plot from the main paper Fig. 2c zoomed in to chromosome 17 with additional bars shown for the arm-level gains (purple) or losses (green). The blue/yellow outline boxes show the genomic regions that are predictive features of the model. The blue box indicates a loss of 17p arm, while the yellow indicates gain of the 17q arm. Tumor suppressor genes or oncogenes are indicated at their chromosomal location at the bottom of each plot.
